Table 1 Baseline characteristics (clinical and demographic)
From: Outcome of highly active antiretroviral therapy in HIV- infected Indian children
Characteristics | Values |
|---|---|
Age (median, IQR) | 119 (75–156) months |
Boys | 131 (74.9) |
Lost one parent | 71 (40.5) |
Lost both parents | 33 (18.9) |
Age at diagnosis (median, IQR) | 58 (29,96) months |
Mode of transmission | |
Perinatal | 142 (81.2) |
Blood transfusion | 6 (3.4) |
Uncertain | 27 (15.4) |
WHO clinical stage at diagnosis | |
1 | 49 (28) |
2 | 50 (28.6) |
3 | 56 (32) |
4 | 20 (11.4) |
WHO immune stage at diagnosis, n = 158 | |
None | 31 (19.6) |
Moderate | 12 (7.6) |
Advanced | 25 (15.8) |
Severe | 90 (57) |
WAZ before starting HAART | |
≥−2 z | 136 (77.7) |
< −2 to> −3 | 14 (8) |
≤−3 | 29 (14.3) |
HAZ before starting HAART | |
≥−2 z | 148 (84.6) |
< −2 to> −3 | 9 (5.1) |
≤−3 | 18 (10.3) |
Received BCG | 109 (62.3) |
History of contact with TB | 60 (34.3 ) |
TB disease diagnosed before initiating HAART | 47 (26.9 ) |
TB developed after initiating HAART | 15 (8.6) |